M1095
Phase 3- Indications
- Plaque psoriasis
Company intelligence / Profile preview
Avillion specializes in partnering with pharmaceutical and biotech companies to accelerate late-stage clinical development, regulatory approval, and commercialization. The company claims a perfect track record of success in bringing high-potential therapies through pivotal trials to market across multiple therapeutic areas. It does not develop its own proprietary drugs but instead co-develops or manages programs for partners.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avillion.